Boston Scientific invests in ICD (implantable cardioverter defibrillator) developer Cameron Health
This article was originally published in Clinica
Executive Summary
Boston Scientific made its second equity investment of the week on February 20 when it agreed to take a stake in Cameron Health. The San Clemente, California-based firm is developing a novel implantable cardioverter defibrillator (ICD).